NCT01758263

Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment

Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment: A Retrospective Database Analysis

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 3,000 (estimated)
• Sponsor: Forest Laboratories · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a retrospective data analysis of patients with high blood pressure (hypertension) who took metoprolol for a minimum of 6 months who then switched to taking nebivolol for a minimum of 6 month to treat hypertension. These patients will be identified from a large medical claims database. This study tests the hypothesis (alternative, higher or lower) that average patient monthly health care administrative cost changes after switching from metoprolol to nebivolol.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Metoprolol	Metoprolol, oral administration
DRUG	Nebivolol	Nebivolol, oral administration

Timeline

• Start date: 2012-10-01
• Primary completion: 2012-12-01
• Completion: 2013-07-01
• First posted: 2013-01-01
• Last updated: 2013-01-01

Locations

1 site across 1 country: United States